SYK STRYKER CORP

Price Chart

Executive Summary

Leerink Partners initiated coverage on Stryker (SYK) at Outperform with a $410 price target, implying 39% upside from the current $294.45. The call aligns with a heavily bullish consensus — 76% Buy-equivalent ratings (28 of 37 analysts). Leerink's 49% accuracy on 257 calls is below the peer average, but its average return of +4.3% is solid. The $410 target sits above the $392 mean and $396 median, signaling above-consensus conviction. Near-term EPS revisions are mixed: +12 upgrades vs 0 downgrades in the last 7 days for the current quarter, but -14 downgrades for the next fiscal year. Insider selling of $1.5M by a director on May 11 is a minor headwind. Institutional flows are divergent — FMR trimmed 42% while Norges Bank initiated a $1.8B position. Short interest at 59.2% of float is extremely elevated, suggesting heavy bearish positioning that could fuel a squeeze if earnings on July 29 deliver upside. Bottom line: a bullish initiation from a mid-tier firm on a heavily loved stock with extreme short interest — watch for a catalyst-driven squeeze into earnings.

Impact Score

Consensus & Targets

Of 37 analysts covering SYK, 28 rate it Buy/Strong Buy (76%), 9 rate it Hold (24%), and 0 rate it Sell. The consensus is overwhelmingly bullish, with no bearish voices. Leerink's Outperform aligns with the majority view, making this a consensus-aligned initiation rather than a contrarian call.

Current price: $294.45. Mean target: $392.19 (implied upside +33%). Median: $396.03. High: $465 (implied +58%). Low: $315 (implied +7%). Leerink's $410 target sits above the mean and median, in the 75th percentile of the range. The wide spread ($315–$465) reflects high conviction dispersion even among bulls.

Recent Analyst Activity

No upgrades or downgrades in the last 30 days — analyst activity is quiet. EPS revisions show a split: current quarter (0q) had +12 upgrades and 0 downgrades in the last 7 days, while next fiscal year (+1y) had +6 upgrades but -14 downgrades. Near-term estimates are being revised up, but longer-term estimates are being cut — a mixed signal.

Firm Track Record — Leerink Partners

Leerink Partners accuracy: 49% on 257 calls | avg return: 4.3%

Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.

Leerink has a 49% accuracy rate on 257 calls, below the peer average. Its average return of +4.3% is respectable but not top-tier. Best-performing firms on SYK include Piper Sandler (100% on 3 calls, +4.8% avg return) and UBS (100% on 3 calls, +6.2% avg return). Worst: Wells Fargo (50% on 6 calls, -0.4% avg return). Leerink's track record is average, reducing the signal's weight.

Earnings Estimates

Next earnings: Jul 29, 2026

Cross-Platform Signals

Insider selling: Director M. Kathryn Fink sold $1.5M on May 11 — a minor bearish signal. Institutional activity is divergent: FMR LLC trimmed 42% of its position ($1.05B), while Norges Bank initiated a massive $1.8B new position. Renaissance Technologies doubled its stake (+294%). Short interest is extremely high at 59.2% of float — a potential squeeze catalyst. The analyst bullishness converges with institutional buying from Norges and Renaissance but diverges from FMR's trimming and insider selling.

Documents Analyzed

Report based on filing metadata.

US Market Status